0001445283-22-000003.txt : 20221229 0001445283-22-000003.hdr.sgml : 20221229 20221229151200 ACCESSION NUMBER: 0001445283-22-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221229 DATE AS OF CHANGE: 20221229 EFFECTIVENESS DATE: 20221229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KINETA, INC./DE CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-469132 FILM NUMBER: 221498608 BUSINESS ADDRESS: STREET 1: 219 TERRY AVE. N. STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: (206) 378-0400 MAIL ADDRESS: STREET 1: 219 TERRY AVE. N. STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140813 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 D 1 primary_doc.xml X0708 D LIVE 0001445283 KINETA, INC./DE 219 TERRY AVE. N. SUITE 300 SEATTLE WA WASHINGTON 98109 (206) 378-0400 DELAWARE YUMANITY THERAPEUTICS, INC. PROTEOSTASIS THERAPEUTICS, INC. PROTEOSTASIS THERAPEUTICS INC Corporation true Shawn Iadonato 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Director Marion R. Foote 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Director Raymond Bartoszek 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Director Richard Peters 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Director David Arkowitz 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Director Craig W. Philips 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Keith A. Baker 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Biotechnology Decline to Disclose 06b false 2022-12-16 false true true The initial sale of the subject securities followed the previously announced merger with Yumanity Therapeutics, Inc.. Such securities were issued to institutional investors and were not offered or issued as consideration in such merger. 0 30000000 7500000 22500000 false 17 0 0 0 false KINETA, INC./DE Shawn P. Iadonato Shawn P. Iadonato Chief Executive Officer 2022-12-28